BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 24071436)

  • 1. Evidence-based treatment of guanidinoacetate methyltransferase (GAMT) deficiency.
    Viau KS; Ernst SL; Pasquali M; Botto LD; Hedlund G; Longo N
    Mol Genet Metab; 2013 Nov; 110(3):255-62. PubMed ID: 24071436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanidinoacetate methyltransferase (GAMT) deficiency: outcomes in 48 individuals and recommendations for diagnosis, treatment and monitoring.
    Stockler-Ipsiroglu S; van Karnebeek C; Longo N; Korenke GC; Mercimek-Mahmutoglu S; Marquart I; Barshop B; Grolik C; Schlune A; Angle B; Araújo HC; Coskun T; Diogo L; Geraghty M; Haliloglu G; Konstantopoulou V; Leuzzi V; Levtova A; Mackenzie J; Maranda B; Mhanni AA; Mitchell G; Morris A; Newlove T; Renaud D; Scaglia F; Valayannopoulos V; van Spronsen FJ; Verbruggen KT; Yuskiv N; Nyhan W; Schulze A
    Mol Genet Metab; 2014 Jan; 111(1):16-25. PubMed ID: 24268530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case study for the evaluation of current treatment recommendations of guanidinoacetate methyltransferase deficiency: ineffectiveness of sodium benzoate.
    Mercimek-Mahmutoglu S; Salomons GS; Chan A
    Pediatr Neurol; 2014 Jul; 51(1):133-7. PubMed ID: 24766785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of newborn screening for guanidinoacetate methyltransferase (GAMT) deficiency.
    Pasquali M; Schwarz E; Jensen M; Yuzyuk T; DeBiase I; Randall H; Longo N
    J Inherit Metab Dis; 2014 Mar; 37(2):231-6. PubMed ID: 24276113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral creatine deficiencies: a group of treatable intellectual developmental disorders.
    Stockler-Ipsiroglu S; van Karnebeek CD
    Semin Neurol; 2014 Jul; 34(3):350-6. PubMed ID: 25192512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of guanidinoacetate in newborn dried blood spots and impact of early treatment in GAMT deficiency.
    El-Gharbawy AH; Goldstein JL; Millington DS; Vaisnins AE; Schlune A; Barshop BA; Schulze A; Koeberl DD; Young SP
    Mol Genet Metab; 2013 Jun; 109(2):215-7. PubMed ID: 23583224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study to estimate incidence of guanidinoacetate methyltransferase deficiency in newborns by direct sequencing of the GAMT gene.
    Mercimek-Mahmutoglu S; Pop A; Kanhai W; Fernandez Ojeda M; Holwerda U; Smith D; Loeber JG; Schielen PC; Salomons GS
    Gene; 2016 Jan; 575(1):127-31. PubMed ID: 26319512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: Human guanidinoacetate n-methyl transferase (GAMT) deficiency: A treatable inborn error of metabolism.
    Iqbal F
    Pak J Pharm Sci; 2015 Nov; 28(6):2207-11. PubMed ID: 26639513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanidinoacetate methyltransferase deficiency (GAMT).
    Gordon N
    Brain Dev; 2010 Feb; 32(2):79-81. PubMed ID: 19289269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective identification by neonatal screening of patients with guanidinoacetate methyltransferase deficiency.
    Hart K; Rohrwasser A; Wallis H; Golsan H; Shao J; Anderson T; Wang X; Szabo-Fresnais N; Morrissey M; Kay DM; Wojcik M; Galvin-Parton PA; Longo N; Caggana M; Pasquali M
    Mol Genet Metab; 2021; 134(1-2):60-64. PubMed ID: 34389248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thirteen new patients with guanidinoacetate methyltransferase deficiency and functional characterization of nineteen novel missense variants in the GAMT gene.
    Mercimek-Mahmutoglu S; Ndika J; Kanhai W; de Villemeur TB; Cheillan D; Christensen E; Dorison N; Hannig V; Hendriks Y; Hofstede FC; Lion-Francois L; Lund AM; Mundy H; Pitelet G; Raspall-Chaure M; Scott-Schwoerer JA; Szakszon K; Valayannopoulos V; Williams M; Salomons GS
    Hum Mutat; 2014 Apr; 35(4):462-9. PubMed ID: 24415674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcome of twenty-two patients with guanidinoacetate methyltransferase deficiency: An international retrospective cohort study.
    Khaikin Y; Sidky S; Abdenur J; Anastasi A; Ballhausen D; Buoni S; Chan A; Cheillan D; Dorison N; Goldenberg A; Goldstein J; Hofstede FC; Jacquemont ML; Koeberl DD; Lion-Francois L; Lund AM; Mention K; Mundy H; O'Rourke D; Pitelet G; Raspall-Chaure M; Tassini M; Billette de Villemeur T; Williams M; Salomons GS; Mercimek-Andrews S
    Eur J Paediatr Neurol; 2018 May; 22(3):369-379. PubMed ID: 29506905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence and Recommendation for Guanidinoacetate Methyltransferase Deficiency Newborn Screening.
    Ream MA; Lam WKK; Grosse SD; Ojodu J; Jones E; Prosser LA; Rose AM; Comeau AM; Tanksley S; Powell CM; Kemper AR
    Pediatrics; 2023 Aug; 152(2):. PubMed ID: 37465909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation in two cousins with guanidinoacetate methyltransferase (GAMT) deficiency presented with autism.
    Aydın Hİ; Sönmez FM
    Turk J Pediatr; 2019; 61(1):92-96. PubMed ID: 31559727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic availability of guanidinoacetate affects GABAA receptor function and seizure threshold in GAMT deficient mice.
    Schulze A; Tran C; Levandovskiy V; Patel V; Cortez MA
    Amino Acids; 2016 Aug; 48(8):2041-7. PubMed ID: 26898547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cerebral creatine deficiency syndromes].
    Malheiro R; Diogo L; Garcia P; Fineza I; Oliveira G
    Acta Med Port; 2012; 25(6):389-98. PubMed ID: 23534590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GAMT deficiency: 20 years of a treatable inborn error of metabolism.
    Braissant O
    Mol Genet Metab; 2014 Jan; 111(1):1-3. PubMed ID: 24275206
    [No Abstract]   [Full Text] [Related]  

  • 18. Method modification to reduce false positives for newborn screening of guanidinoacetate methyltransferase deficiency.
    Wojcik M; Morrissey M; Borden K; Teta B; Sicko R; Showers A; Sunny S; Caggana M
    Mol Genet Metab; 2022 Mar; 135(3):186-192. PubMed ID: 35120844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presymptomatic treatment of neonatal guanidinoacetate methyltransferase deficiency.
    Schulze A; Hoffmann GF; Bachert P; Kirsch S; Salomons GS; Verhoeven NM; Mayatepek E
    Neurology; 2006 Aug; 67(4):719-21. PubMed ID: 16924036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanidinoacetate methyltransferase deficiency: first steps to newborn screening for a treatable neurometabolic disease.
    Mercimek-Mahmutoglu S; Sinclair G; van Dooren SJ; Kanhai W; Ashcraft P; Michel OJ; Nelson J; Betsalel OT; Sweetman L; Jakobs C; Salomons GS
    Mol Genet Metab; 2012 Nov; 107(3):433-7. PubMed ID: 23031365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.